Citric Acid, Sodium Citrate, and Potassium Citrate and Ibritumomab
Determining the interaction of Citric Acid, Sodium Citrate, and Potassium Citrate and Ibritumomab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: citric acid / potassium citrate / sodium citrate
Brand name: Cytra-3, Polycitra, Polycitra-LC, Tricitrates, Virtrate-3
Synonyms: Citric acid, potassium citrate, and sodium citrate
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Citric Acid, Sodium Citrate, and Potassium Citrate-Ibritumomab Intravenous
- Citric Acid, Sodium Citrate, and Potassium Citrate-Ibritumomab Tiuxetan
- Citric Acid, Sodium Citrate, and Potassium Citrate-Ibrutinib
- Citric Acid, Sodium Citrate, and Potassium Citrate-Ibrutinib Capsules
- Citric Acid, Sodium Citrate, and Potassium Citrate-Ibrutinib Tablets
- Citric Acid, Sodium Citrate, and Potassium Citrate-Ibu
- Ibritumomab-Citroma
- Ibritumomab-Citrucel
- Ibritumomab-Citrucel (Methylcellulose Powder and Powder Packets)
- Ibritumomab-Citrucel (Methylcellulose Tablets)
- Ibritumomab-Citrucel Tablets
- Ibritumomab-Cladribine